Elite in Hemolytic Anemia

Giovanna Cannas

Lyon, FR 
Elite in Hemolytic Anemia
Lyon, FR 
OverviewLocationsClinical Research

Overview

Giovanna Cannas practices in Lyon, France. Ms. Cannas is rated as an Elite expert by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 56 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 45 articles and participated in 6 clinical trials in the study of Hemolytic Anemia.

Gender
Female

Locations

Lyon, France
Other Locations
Auvergny, France
Raray, France
Paris, France
Villeurbanne, France
Pierre-la-treiche, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Relationships Between Hemolysis, Erythrosis, Circulating Microparticles and Vascular Function in Patients With Hereditary Spherocytosis
Relationships Between Hemolysis, Erythrosis, Circulating Microparticles and Vascular Function in Patients With Hereditary Spherocytosis
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Diagnostic test, Biological
Study Phase: Not Applicable
Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Enrollment Status: Completed
Publish Date: May 14, 2025
Intervention Type: Drug
Study Drug: Hydroxycarbamide
Study Phase: Phase 2
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2024
Intervention Type: Drug
Effects of Obstructive Sleep Apnea on the Frequency of Vaso-occlusive Crises Events and Bio-physical Markers in Sickle Cell Disease
Effects of Obstructive Sleep Apnea on the Frequency of Vaso-occlusive Crises Events and Bio-physical Markers in Sickle Cell Disease
Enrollment Status: Terminated
Publish Date: December 28, 2022
Intervention Type: Other, Biological, Diagnostic test
Study Drugs: Calculation of VOC frequency between the first polysomnography and the end of the first year of continuous positive airway pressure treatment, Blood samples
Study Phase: Not Applicable
ESCORT-HU : European Sickle Cell Disease Cohort - Hydroxyurea
ESCORT-HU : European Sickle Cell Disease Cohort - Hydroxyurea
Enrollment Status: Completed
Publish Date: March 19, 2020
Intervention Type: Drug
Muscle Function and Its Biological and Physiological Determinants in Sickle Cell Disease
Muscle Function and Its Biological and Physiological Determinants in Sickle Cell Disease
Enrollment Status: Completed
Publish Date: January 29, 2020
Intervention Type: Other, Biological
Study Phase: Not Applicable
View 5 Less Clinical Trials

56 Total Publications

Health-Related Quality of Life Measurement in Adults With Sickle Cell Disease in Steady State: Experience of One French Reference Center.
Health-Related Quality of Life Measurement in Adults With Sickle Cell Disease in Steady State: Experience of One French Reference Center.
Journal: Mediterranean journal of hematology and infectious diseases
Published: July 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cannas's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile